Amisulpride 200mg tablets

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

купити це зараз

Активний інгредієнт:

Amisulpride

Доступна з:

Accord-UK Ltd

Код атс:

N05AL05

ІПН (Міжнародна Ім'я):

Amisulpride

Дозування:

200mg

Фармацевтична форма:

Oral tablet

Адміністрація маршрут:

Oral

Клас:

No Controlled Drug Status

Тип рецепту:

Valid as a prescribable product

Огляд продуктів:

BNF: 04020100; GTIN: 5012617015921

інформаційний буклет

                                LOGO ACCORD
AMISULPRIDE 50MG, 100MG, AND 200MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN.
•
IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR, PHARMACIST OR
NURSE.
•
THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT ON TO
OTHERS. IT MAY HARM
THEM, EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS.
•
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet.
WHAT IS IN THIS LEAFLET: _ _
1.
WHAT AMISULPRIDE TABLETS ARE AND WHAT THEY ARE USED FOR
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE AMISULPRIDE TABLETS
3.
HOW TO TAKE AMISULPRIDE TABLETS
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE AMISULPRIDE TABLETS
6.
CONTENTS OF THE PACK AND OTHER INFORMATION
1. WHAT AMISULPRIDE TABLETS ARE AND WHAT THEY ARE USED FOR
Amisulpride tablets
contain the active substance amisulpride which belong to a group of
medicines called benzamide
antipsychotics. These work by improving thoughts, feelings and/or
behaviour when these are disturbed
in certain medical conditions.
Amisulpride tablets may be used in the treatment of acute (severe or
sudden) and chronic (ongoing or
long-term) schizophrenia, a condition where certain symptoms become
very noticeable. These include
feeling, hearing or seeing things that aren’t really there
(hallucinations), having a strong false belief
despite evidence against it (delusions), inability to think normally,
and feeling emotional, disinterested
or withdrawn.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE AMISULPRIDE TABLETS
DO NOT TAKE AMISULPRIDE TABLETS IF YOU:
•
are
BREASTFEEDING
•
are allergic to amisulpride or any of the other ingredients of this
medicine (listed in section 6) have
a
TUMOUR
that depends on prolactin (a hormone produced by the pituitary gland)
or
BREAST CANCER
•
have
PHAEOCHROMOCYTOMA
(a tumour of the adrenal gland causing high blood pressure)

                                
                                Прочитайте повний документ
                                
                            

Характеристики продукта

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
AMISULPRIDE 200mg TABLETS
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 200.000mg Amisulpride.
Excipient with known effect: Lactose monohydrate
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablet.
White to off-white, round tablets with a break line, diameter 12.5mm
and
impressed “C” and “AM” on one face.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Amisulpride is indicated for the treatment of acute and chronic
schizophrenic
disorders, in which positive symptoms (such as delusions,
hallucinations,
thought
disorders)
and/or
negative
symptoms
(such
as
blunted
affect,
emotional
and
social
withdrawal)
are
prominent,
including
patients
characterised by predominant negative symptoms.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
For acute psychotic episodes, oral doses between 400 mg per day and
800 mg
per day are recommended. In individual cases, the daily dose may be
increased
up to 1200 mg per day. Doses above 1200 mg per day have not been
extensively evaluated for safety and therefore should not be used. No
specific
titration is required when initiating the treatment with Amisulpride.
Doses
should be adjusted according to individual response.
For patients with mixed positive and negative symptoms, doses should
be
adjusted to obtain optimal control of positive symptoms.
Maintenance treatment should be established individually with the
minimally
effective dose.
For patients characterised by predominant negative symptoms, oral
doses
between 50 mg per day and 300 mg per day are recommended. Doses should
be adjusted individually.
Amisulpride can be administered once daily at oral doses up to 300 mg,
higher
doses should be administered twice daily.
_Elderly _
Amisulpride should be used with particular caution because of a
possible risk
of hypotension or sedation.
Amisulpride should be used with particular caution because of a
possible risk
of hypotension and sedation. Reduction in dosage may a
                                
                                Прочитайте повний документ
                                
                            

Сповіщення про пошук, пов’язані з цим продуктом

Переглянути історію документів